A two-drug regimen improved outcomes for patients with myeloma when given before a stem cell transplant.
Loretta Williams
Advertisement
Articles by Loretta Williams
Advertisement
Latest Updated Articles
Two-Drug Combo Improves Post-Transplant Myeloma OutcomesPublished: June 7th 2018 | Updated:
Advertisement
Advertisement
Trending on CURE
1
B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma
2
Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma
3
Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial
4
Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma
5
